Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease

CONTEXT: Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients. AGEs proved to be a marker of negative outcome in both diabetes management and surgical procedures in these patients. The report...

Descripción completa

Detalles Bibliográficos
Autores principales: Nenna, Antonio, Nappi, Francesco, Avtaar Singh, Sanjeet Singh, Sutherland, Fraser W., Di Domenico, Fabio, Chello, Massimo, Spadaccio, Cristiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571620/
https://www.ncbi.nlm.nih.gov/pubmed/26393232
http://dx.doi.org/10.5812/cardiovascmed.4(2)2015.26949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571620/
https://www.ncbi.nlm.nih.gov/pubmed/26393232
http://dx.doi.org/10.5812/cardiovascmed.4(2)2015.26949

Ejemplares similares